Aris Baras

Senior Vice President, Head of Regeneron Genetics Center, Co-Head of Regeneron Genetic Medicines · Regeneron Pharmaceuticals

Biopharmaceuticals

Aris Baras is senior vice president, head of the Regeneron Genetics Center and co-head of Regeneron Genetic Medicines at Regeneron Pharmaceuticals. He joined in 2011 and helped found the company’s genetics center.

Last reviewed: Oct 21, 2026

Aris Baras

Senior Vice President, Head of Regeneron Genetics Center, Co-Head of Regeneron Genetic Medicines Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Aris Baras is senior vice president, head of the Regeneron Genetics Center and co-head of Regeneron Genetic Medicines at Regeneron Pharmaceuticals. He joined in 2011 and helped found the company’s genetics center.

Career Highlights

  • Joined Regeneron in 2011.
  • Helped found the Regeneron Genetics Center.
  • Now leads the center and co-leads Regeneron Genetic Medicines.

Professional Journey

Before Regeneron, Baras contributed to biotechnology ventures and conducted research involving antibody therapeutics, cancer and nanotechnology applications in drug development. His education at Duke University combined medicine, business and undergraduate study.

He joined Regeneron in 2011 and held responsibilities across research and development and business development. He also helped establish the Regeneron Genetics Center.

He now serves as senior vice president and head of the center, alongside his role as co-head of Regeneron Genetic Medicines. His progression connects research and business development experience with leadership of the company’s human genetics and genetic medicines activities.

Education

Baras earned a BS, MBA and MD from Duke University.